Cargando…
Involvement in the US criminal justice system and cost implications for persons treated for schizophrenia
BACKGROUND: Individuals with schizophrenia may have a higher risk of encounters with the criminal justice system than the general population, but there are limited data on such encounters and their attendant costs. This study assessed the prevalence of encounters with the criminal justice system, en...
Autores principales: | , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2848217/ https://www.ncbi.nlm.nih.gov/pubmed/20109170 http://dx.doi.org/10.1186/1471-244X-10-11 |
_version_ | 1782179659533778944 |
---|---|
author | Ascher-Svanum, Haya Nyhuis, Allen W Faries, Douglas E Ball, Daniel E Kinon, Bruce J |
author_facet | Ascher-Svanum, Haya Nyhuis, Allen W Faries, Douglas E Ball, Daniel E Kinon, Bruce J |
author_sort | Ascher-Svanum, Haya |
collection | PubMed |
description | BACKGROUND: Individuals with schizophrenia may have a higher risk of encounters with the criminal justice system than the general population, but there are limited data on such encounters and their attendant costs. This study assessed the prevalence of encounters with the criminal justice system, encounter types, and the estimated cost attributable to these encounters in the one-year treatment of persons with schizophrenia. METHODS: This post-hoc analysis used data from a prospective one-year cost-effectiveness study of persons treated with antipsychotics for schizophrenia and related disorders in the United States. Criminal justice system involvement was assessed using the Schizophrenia Patients Outcome Research Team (PORT) client survey and the victimization subscale of the Lehman Quality of Life Interview (QOLI). Direct cost of criminal justice system involvement was estimated using previously reported costs per type of encounter. Patients with and without involvement were compared on baseline characteristics and direct annual health care and criminal justice system-related costs. RESULTS: Overall, 278 (46%) of 609 participants reported at least 1 criminal justice system encounter. They were more likely to be substance users and less adherent to antipsychotics compared to participants without involvement. The 2 most prevalent types of encounters were being a victim of a crime (67%) and being on parole or probation (26%). The mean annual per-patient cost of involvement was $1,429, translating to 6% of total annual direct health care costs for those with involvement (11% when excluding crime victims). CONCLUSIONS: Criminal justice system involvement appears to be prevalent and costly for persons treated for schizophrenia in the United States. Findings highlight the need to better understand the interface between the mental health and the criminal justice systems and the related costs, in personal, societal, and economic terms. |
format | Text |
id | pubmed-2848217 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-28482172010-04-01 Involvement in the US criminal justice system and cost implications for persons treated for schizophrenia Ascher-Svanum, Haya Nyhuis, Allen W Faries, Douglas E Ball, Daniel E Kinon, Bruce J BMC Psychiatry Research article BACKGROUND: Individuals with schizophrenia may have a higher risk of encounters with the criminal justice system than the general population, but there are limited data on such encounters and their attendant costs. This study assessed the prevalence of encounters with the criminal justice system, encounter types, and the estimated cost attributable to these encounters in the one-year treatment of persons with schizophrenia. METHODS: This post-hoc analysis used data from a prospective one-year cost-effectiveness study of persons treated with antipsychotics for schizophrenia and related disorders in the United States. Criminal justice system involvement was assessed using the Schizophrenia Patients Outcome Research Team (PORT) client survey and the victimization subscale of the Lehman Quality of Life Interview (QOLI). Direct cost of criminal justice system involvement was estimated using previously reported costs per type of encounter. Patients with and without involvement were compared on baseline characteristics and direct annual health care and criminal justice system-related costs. RESULTS: Overall, 278 (46%) of 609 participants reported at least 1 criminal justice system encounter. They were more likely to be substance users and less adherent to antipsychotics compared to participants without involvement. The 2 most prevalent types of encounters were being a victim of a crime (67%) and being on parole or probation (26%). The mean annual per-patient cost of involvement was $1,429, translating to 6% of total annual direct health care costs for those with involvement (11% when excluding crime victims). CONCLUSIONS: Criminal justice system involvement appears to be prevalent and costly for persons treated for schizophrenia in the United States. Findings highlight the need to better understand the interface between the mental health and the criminal justice systems and the related costs, in personal, societal, and economic terms. BioMed Central 2010-01-28 /pmc/articles/PMC2848217/ /pubmed/20109170 http://dx.doi.org/10.1186/1471-244X-10-11 Text en Copyright ©2010 Ascher-Svanum et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research article Ascher-Svanum, Haya Nyhuis, Allen W Faries, Douglas E Ball, Daniel E Kinon, Bruce J Involvement in the US criminal justice system and cost implications for persons treated for schizophrenia |
title | Involvement in the US criminal justice system and cost implications for persons treated for schizophrenia |
title_full | Involvement in the US criminal justice system and cost implications for persons treated for schizophrenia |
title_fullStr | Involvement in the US criminal justice system and cost implications for persons treated for schizophrenia |
title_full_unstemmed | Involvement in the US criminal justice system and cost implications for persons treated for schizophrenia |
title_short | Involvement in the US criminal justice system and cost implications for persons treated for schizophrenia |
title_sort | involvement in the us criminal justice system and cost implications for persons treated for schizophrenia |
topic | Research article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2848217/ https://www.ncbi.nlm.nih.gov/pubmed/20109170 http://dx.doi.org/10.1186/1471-244X-10-11 |
work_keys_str_mv | AT aschersvanumhaya involvementintheuscriminaljusticesystemandcostimplicationsforpersonstreatedforschizophrenia AT nyhuisallenw involvementintheuscriminaljusticesystemandcostimplicationsforpersonstreatedforschizophrenia AT fariesdouglase involvementintheuscriminaljusticesystemandcostimplicationsforpersonstreatedforschizophrenia AT balldaniele involvementintheuscriminaljusticesystemandcostimplicationsforpersonstreatedforschizophrenia AT kinonbrucej involvementintheuscriminaljusticesystemandcostimplicationsforpersonstreatedforschizophrenia |